UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000035235
Receipt number R000040151
Scientific Title nab-Paclitaxel plus trastuzumab and pertuzumab followed by EC as a neoadjuvant chemotherapy for HER2-positive operable breast cancer
Date of disclosure of the study information 2018/12/12
Last modified on 2023/12/16 14:16:17

No. Disposal Last modified on Item of update
1 Insert 2018/12/12 22:49:04
2 Update 2020/06/13 10:29:33 Recruitment status
Date of IRB
Last follow-up date
3 Update 2020/12/13 09:15:33 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Institute
Nationality of Funding Organization
Nationality of Funding Organization
Email3
Organization
Organization
Address
Address
Tel
Email
4 Update 2021/12/14 12:53:31 Results Delayed
Results Delay Reason
Results Delay Reason
Date of the first journal publication of results
5 Update 2023/12/16 14:16:17 Date analysis concluded